Suppr超能文献

阿尔茨海默病诊断的临床标准:历经岁月仍具价值。

Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years.

作者信息

Ranginwala Najeeb A, Hynan Linda S, Weiner Myron F, White Charles L

机构信息

Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Am J Geriatr Psychiatry. 2008 May;16(5):384-8. doi: 10.1097/JGP.0b013e3181629971.

Abstract

OBJECTIVE

To examine the impact of newer neuropathological techniques on the power of National Institute of Neurological and Communicative Disorders and Stroke-AD and Related Disorders Association criteria for Alzheimer disease (AD) to detect AD at later postmortem study.

DESIGN

We examined clinical and postmortem diagnoses of persons evaluated postmortem with thioflavin-S staining for plaques and tangles and immunohistochemical staining techniques for alpha synuclein, uhiquitin, and tau protein.

SETTING

Alzheimer Disease Center.

PARTICIPANTS

Clinically evaluated persons for whom tissue diagnosis was available.

RESULTS

Of 313 evaluees, 166 met criteria for probable AD. An additional 59 subjects had clinical diagnoses that included AD, e.g., possible AD, Lewy body variant of AD, AD and Parkinsonism, and mixed AD and vascular dementia. Of the 166 probable AD cases, 147 of 166 (88.6%) met pathologic criteria for AD. When all five AD groups were combined, 194 of 225 subjects (86.2%) met pathologic criteria for AD. There were five cases diagnosed pathologically as tangle-only dementia, which was considered a variant of AD. A pathologic diagnosis of Lewy body variant of AD was made in 56 (17.9%) of cases, including 44 of 313 (14.1%) cases diagnosed as probable or possible AD. Pure dementia with Lewy bodies was seen in 13 (4.2%). There were 9 (2.9%) cases of mixed AD and vascular dementia, and 37 (11.4%) cases of frontotemporal dementia.

CONCLUSIONS

McKhann et al. criteria for probable and possible AD are valid for AD but do not exclude additional Lewy body pathology.

摘要

目的

探讨更新的神经病理学技术对美国国立神经疾病与中风研究所-阿尔茨海默病及相关疾病协会(NINCDS-ADRDA)阿尔茨海默病(AD)诊断标准在死后研究中检测AD能力的影响。

设计

我们检查了死后通过硫黄素-S染色检测斑块和缠结以及α-突触核蛋白、泛素和tau蛋白免疫组织化学染色技术进行评估的患者的临床和死后诊断。

地点

阿尔茨海默病中心。

参与者

有组织诊断结果的临床评估患者。

结果

在313名被评估者中,166人符合可能AD的标准。另外59名受试者的临床诊断包括AD,如可能AD、AD路易体变异型、AD合并帕金森病以及AD合并血管性痴呆。在166例可能AD病例中,166例中的147例(88.6%)符合AD的病理标准。当将所有五个AD组合并时,225名受试者中的194名(86.2%)符合AD的病理标准。有5例病理诊断为单纯缠结性痴呆,这被认为是AD的一种变异型。AD路易体变异型的病理诊断在56例(17.9%)病例中作出,包括313例中的44例(14.1%)被诊断为可能或很可能AD的病例。单纯路易体痴呆见于13例(4.2%)。有9例(2.9%)AD合并血管性痴呆,37例(11.4%)额颞叶痴呆。

结论

McKhann等人的可能和很可能AD标准对AD有效,但不排除额外的路易体病理改变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验